Breaking News Instant updates and real-time market news.

ACHC

Acadia

$45.19

1.75 (4.03%)

07:47
10/19/16
10/19
07:47
10/19/16
07:47

Acadia price target lowered to $55 from $79 at UBS

UBS analyst A.J. Rice lowered his price target on Acadia to $55 from $79 following its below consensus Q3 results. The analyst noted the company saw a surprise slowdown in U.S. growth and said it is still assessing the reason for the slowdown. Rice adjusted his estimates to reflect the revenue growth and margin trends. Rice maintained his Buy rating on Acadia shares.

ACHC Acadia
$45.19

1.75 (4.03%)

06/27/16
JEFF
06/27/16
NO CHANGE
Target $85
JEFF
Acadia pullback Friday a buying opportunity, says Jefferies
Jefferies analyst Brian Tanquilut views Friday's pullback in shares of Acadia Healthcare as overdone. The company's exposure to the Brisith pound weakness is fairly minimal, and investors can now focus on fundamentals with the Brexit vote done, Tanquilut tells investors in a research note. The analyst left recent meetings with management "even more bullish" on Acadia's fundamentals and growth outlook. He keeps a Buy rating on the shares with an $85 price target.
06/28/16
LEER
06/28/16
NO CHANGE
LEER
Outperform
Acadia more exposed to the U.K. but sell-off appears 'overdone,' says Leerink
Leerink analyst Ana Gupte believes Managed Care Organizations will be immune from Brexit, as they are macro defensive with minimal earnings exposure. However, the analyst notes that Acadia Healthcare is the "most exposed" to the U.K. among the Managed Care names in her coverage, but says she expects modest EBITDA downside at about 4% for fiscal year 2017. Gupte recommends Acadia as a buying opportunity amid the stock's sell-off. Leerink has an Outperform rating on the shares.
07/15/16
JEFF
07/15/16
NO CHANGE
Target $85
JEFF
Buy
Acadia selloff yesterday a buying opportunity, says Jefferies
Jefferies analyst Brian Tanquilut believes Acadia Healthcare investors overreacted to the U.K.'s Competition & Markets Authority expressing anti-competitive concerns in 20 of the company's U.K. markets due to its Priory acquisition. Acadia management is committed to pursuing a compromise that is acceptable to the agency within the next five that should lead to final approval of the Priory deal by July 28, Tanquilut tells investors in a research note. He views yesterday's pullback in Acadia shares as a buying opportunity. The analyst keeps a Buy rating on the name with an $85 price target.
10/19/16
RBCM
10/19/16
NO CHANGE
RBCM
Acadia still has positive catalysts despite ' stumble,' says RBC Capital
RBC Capital analyst Frank Morgan says that Acadia's Q3 miss was "a stumble," driven partly by the resolution of its Priory antitrust issues. The analyst thinks that the stock could drop another 5%-10%, but he says that its Q4 results and its reinvestment of the $390M of proceeds from the Priory deal should provide positive catalysts for the shares. The analyst keeps a $59 price target and Outperform rating on the stock.

TODAY'S FREE FLY STORIES

NVDQ

Novadaq

$6.59

-0.01 (-0.15%)

, CI

Cigna

$146.52

2.96 (2.06%)

15:57
02/21/17
02/21
15:57
02/21/17
15:57
Hot Stocks
LifeNet says Dermacell receives coverage from Cigna »

Cigna (CI) now covers…

NVDQ

Novadaq

$6.59

-0.01 (-0.15%)

CI

Cigna

$146.52

2.96 (2.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 28

    Feb

  • 28

    Feb

PBYI

Puma Biotechnology

$40.25

2.9 (7.76%)

15:56
02/21/17
02/21
15:56
02/21/17
15:56
Options
Puma Biotechnology put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 21

    Jul

SODA

SodaStream

$47.14

-0.53 (-1.11%)

15:54
02/21/17
02/21
15:54
02/21/17
15:54
Hot Stocks
Teleios Capital lowers stake in SodaStream to 4.5% »

Teleios Capital has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOMO

Momo

$27.00

0.2 (0.75%)

15:48
02/21/17
02/21
15:48
02/21/17
15:48
Hot Stocks
Matrix Partners China lowers stake in Momo to 12.6% from 15.4% »

On September 23, 2016,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Mar

BMY

Bristol-Myers

$53.55

-1.04 (-1.91%)

15:38
02/21/17
02/21
15:38
02/21/17
15:38
Hot Stocks
Breaking Hot Stocks news story on Bristol-Myers »

Bristol-Myers up 2.5%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 22

    Feb

  • 02

    Mar

  • 17

    Mar

  • 01

    Apr

BMY

Bristol-Myers

$53.54

-1.05 (-1.92%)

15:38
02/21/17
02/21
15:38
02/21/17
15:38
Periodicals
Carl Icahn takes stake in Bristol-Myers, WSJ reports »

Icahn sees value in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 22

    Feb

  • 02

    Mar

  • 17

    Mar

  • 01

    Apr

DEPO

Depomed

$16.47

-0.38 (-2.26%)

15:35
02/21/17
02/21
15:35
02/21/17
15:35
Options
Depomed options imply 6.4% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

CSCO

Cisco

$33.74

0.14 (0.42%)

15:32
02/21/17
02/21
15:32
02/21/17
15:32
Conference/Events
Cisco to host service provider tech talk »

Cisco SVP Kanouff hosts a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 03

    Mar

EFA

iShares MSCI EAFE Index Fund

$60.65

0.15 (0.25%)

15:31
02/21/17
02/21
15:31
02/21/17
15:31
Options
Defensive option play opened in the iShares MSCI EAFE Fund »

Defensive option play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUAN

Nuance

$16.96

0.1 (0.59%)

15:26
02/21/17
02/21
15:26
02/21/17
15:26
Options
Nuance call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRBP

Corbus Pharmaceuticals

$8.85

0.55 (6.63%)

15:25
02/21/17
02/21
15:25
02/21/17
15:25
Conference/Events
Cantor Fitzgerald health/pharma analysts hold analyst/industry conference call »

Analysts, along with Key…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 13

    Mar

$NSD

NASDAQ Market Internals

15:21
02/21/17
02/21
15:21
02/21/17
15:21
Technical Analysis
NASDAQ Market Internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

15:21
02/21/17
02/21
15:21
02/21/17
15:21
Technical Analysis
NYSE Market Internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENT

Global Eagle

$6.22

-0.01 (-0.16%)

15:21
02/21/17
02/21
15:21
02/21/17
15:21
Downgrade
Global Eagle rating change  »

Global Eagle downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

  • 28

    Feb

  • 06

    Mar

ARLZ

Aralez

$4.50

-0.02 (-0.44%)

, AMGN

Amgen

$173.29

1.18 (0.69%)

15:20
02/21/17
02/21
15:20
02/21/17
15:20
Hot Stocks
Bass group fails to prove Aralez patent claims unpatentable »

The Coalition For…

ARLZ

Aralez

$4.50

-0.02 (-0.44%)

AMGN

Amgen

$173.29

1.18 (0.69%)

BIIB

Biogen

$288.94

-1.19 (-0.41%)

ABBV

AbbVie

$61.66

-0.1147 (-0.19%)

JNJ

Johnson & Johnson

$119.49

0.63 (0.53%)

SHPG

Shire

$181.08

2.38 (1.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 21

    Feb

  • 22

    Feb

  • 22

    Feb

  • 24

    Feb

  • 06

    Mar

  • 07

    Mar

  • 09

    Mar

  • 14

    Mar

  • 17

    Mar

  • 21

    Mar

  • 27

    Mar

  • 01

    Apr

  • 26

    Jun

  • 19

    Jul

HCLP

Hi-Crush Partners

$21.58

0.275 (1.29%)

15:20
02/21/17
02/21
15:20
02/21/17
15:20
Options
Hi Crush options imply 9.5% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 28

    Feb

TWTR

Twitter

$16.42

-0.2 (-1.20%)

15:18
02/21/17
02/21
15:18
02/21/17
15:18
Hot Stocks
Twitter head of entertainment talent resigns »

Lara Cohen, head of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 23

    Feb

  • 28

    Feb

  • 19

    Mar

KRP

Kimbell Royalty Partners

$19.90

0.15 (0.76%)

15:16
02/21/17
02/21
15:16
02/21/17
15:16
Hot Stocks
Breaking Hot Stocks news story on Kimbell Royalty Partners »

Rivercrest Royalties…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GT

Goodyear Tire

$36.07

-0.09 (-0.25%)

15:16
02/21/17
02/21
15:16
02/21/17
15:16
Options
Goodyear Tire put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABX

Barrick Gold

$20.11

-0.06 (-0.30%)

15:16
02/21/17
02/21
15:16
02/21/17
15:16
Conference/Events
Barrick Gold to hold a conference call »

Management provides an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

MARA

Marathon Patent Group

$1.34

-0.04 (-2.90%)

, HON

Honeywell

$124.79

0.2317 (0.19%)

15:15
02/21/17
02/21
15:15
02/21/17
15:15
Hot Stocks
Marathon Patent unit files patent infringement suits against Honeywell, Somfy »

Marathon Patent Group…

MARA

Marathon Patent Group

$1.34

-0.04 (-2.90%)

HON

Honeywell

$124.79

0.2317 (0.19%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

  • 01

    Mar

  • 29

    Mar

  • 24

    Apr

15:15
02/21/17
02/21
15:15
02/21/17
15:15
General news
Breaking General news story  »

San Francisco Federal…

RDS.A

Royal Dutch Shell

$52.48

0.275 (0.53%)

15:13
02/21/17
02/21
15:13
02/21/17
15:13
Conference/Events
Royal Dutch Shell to hold a conference call »

EVP of Gas and Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PBYI

Puma Biotechnology

$40.25

2.9 (7.76%)

, RHHBY

Roche

$30.53

0.02 (0.07%)

15:11
02/21/17
02/21
15:11
02/21/17
15:11
Hot Stocks
Before the Move: Watch Puma Biotech into data on breast cancer rival »

Ahead of Roche's…

PBYI

Puma Biotechnology

$40.25

2.9 (7.76%)

RHHBY

Roche

$30.53

0.02 (0.07%)

IBB

iShares Nasdaq Biotechnology Index

$294.35

1.37 (0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 27

    Feb

  • 09

    Mar

  • 26

    Jun

  • 21

    Jul

XPO

XPO Logistics

$48.50

-0.72 (-1.46%)

15:05
02/21/17
02/21
15:05
02/21/17
15:05
Options
XPO Logistics options imply 10.8% move in share price post-earnings, above median historical move »

Pre-earnings options…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.